Direxion Daily S&P Biotech Bear 3X Shares – AMEX:LABD

Add to watchlist

-0.94

-13.54%

Market open

Closed in about 3 hours

+15.28%

month

+15.28%

quarter

-24.57%

year

Market Cap	67.84M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Direxion Daily S&P Biotech Bear 3X Shares
Latest News

Tuesday, 19 November 2024
12:15	Top Performing Leveraged/Inverse ETFs: 11/17/2024	etftrends.com
Wednesday, 1 May 2024
13:00	5 Inverse ETFs That Gained More Than 20% in April	Zacks Investment Research
Tuesday, 23 April 2024
15:36	Top Performing Leveraged/Inverse ETFs: 04/21/2024	ETF Trends
09:00	5 Best Inverse-Leveraged ETFs of Last Week	Zacks Investment Research
Tuesday, 9 April 2024
13:11	Top Performing Leveraged/Inverse ETFs: 04/07/2024	ETF Trends
Tuesday, 19 March 2024
15:08	Top Performing Leveraged/Inverse ETFs: 03/17/2024	ETF Trends
Monday, 18 March 2024
09:00	Best Inverse/Leveraged ETFs of Last Week	Zacks Investment Research
Friday, 26 January 2024
08:28	Early IPO Activity Could Spell Bullishness for Biotech Industry	ETF Trends
Friday, 5 January 2024
17:56	LABD: An Absolute Avoid	Seeking Alpha
Tuesday, 14 November 2023
15:53	Top Performing Leveraged/Inverse ETFs: 11/12/2023	ETF Trends
Monday, 13 November 2023
09:02	Best Inverse/Leveraged ETFs of Last Week	Zacks Investment Research
Wednesday, 1 November 2023
12:47	5 Inverse ETFs That Gained More Than 25% in October	Zacks Investment Research
Tuesday, 31 October 2023
15:29	Top Performing Leveraged/Inverse ETFs: 10/29/2023	ETF Trends
Monday, 30 October 2023
14:17	Best Inverse/Leveraged ETFs of Last Week	Zacks Investment Research
Tuesday, 10 October 2023
09:01	Best Inverse/Leveraged ETFs of Last Week	Zacks Investment Research
Friday, 29 September 2023
16:50	LABU And LABD: Another Attractive Double-Short Pairs Trade	Seeking Alpha
Tuesday, 26 September 2023
16:18	Top Performing Leveraged/Inverse ETFs: 09/24/2023	ETF Trends
09:01	Best Inverse/Leveraged ETFs of Last Week	Zacks Investment Research
Tuesday, 12 September 2023
14:48	Top Performing Leveraged/Inverse ETFs: 09/10/2023	ETF Trends
Friday, 1 September 2023
12:49	5 Inverse ETFs That Gained in Double Digits in August	Zacks Investment Research
Wednesday, 9 August 2023
12:12	Inverse ETFs Soar as Market Turns Sour	Zacks Investment Research
Tuesday, 8 August 2023
14:11	Top Performing Leveraged/Inverse ETFs: 08/06/2023	ETF Trends
Friday, 21 July 2023
15:03	LABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best Avoided	Seeking Alpha
Thursday, 22 June 2023
10:21	5 Factors Why Inverse ETFs May Rule in 2H23	Zacks Investment Research
Sunday, 14 May 2023
07:47	May MDA Breakout Stocks/ETFs Week 20 - 2023: High-Frequency Gainers To Give You An Edge	Seeking Alpha
Wednesday, 19 April 2023
14:13	Leveraged Biotech ETFs: Hold LABU, Sell LABD	Seeking Alpha
Tuesday, 28 March 2023
16:21	Top Performing Leveraged/Inverse ETFs: 03/26/2023	ETF Trends
Monday, 27 March 2023
09:11	5 Best Leveraged ETFs of Last Week	Zacks Investment Research
Sunday, 26 March 2023
09:16	MDA Breakout Stocks/ETFs Week 13 - March 2023: High-Frequency Gainers To Give You An Edge	Seeking Alpha
Thursday, 23 March 2023
09:54	ETF Winners From the Fed Meeting & Yellen's Testimony	Zacks Investment Research

Ideas & Opinions

Seeking Alpha 21 May 2023

May MDA Breakout Stocks/ETFs Week 21 - 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha 14 May 2023

May MDA Breakout Stocks/ETFs Week 20 - 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha 26 Mar 2023

MDA Breakout Stocks/ETFs Week 13 - March 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha 19 Mar 2023

MDA Breakout Stocks/ETFs Week 12 - March 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha 12 Mar 2023

MDA Breakout Stocks/ETFs Week 11 - March 2023: High-Frequency Gainers To Give You An Edge
Seeking Alpha 24 Aug 2022

CytoDyn: It Only Takes One Hit
Seeking Alpha 24 Aug 2022

Coherus: 2022 Is In Many Ways A Make Or Break Year
Seeking Alpha 23 Aug 2022

Can Intellia One-Up Alnylam In Transthyretin Amyloidosis?
Seeking Alpha 15 Aug 2022

Selecta: ImmTOR Could Change Autoimmune Disorder Treatment Landscape
Seeking Alpha 1 Aug 2022

SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play

Frequently Asked Questions (FAQ)

What's the price of Direxion Daily S&P Biotech Bear 3X Shares stock today?

One share of Direxion Daily S&P Biotech Bear 3X Shares stock can currently be purchased for approximately $6.
When is Direxion Daily S&P Biotech Bear 3X Shares's next earnings date?

Unfortunately, Direxion Daily S&P Biotech Bear 3X Shares's (LABD) next earnings date is currently unknown.
Does Direxion Daily S&P Biotech Bear 3X Shares pay dividends?

No, Direxion Daily S&P Biotech Bear 3X Shares does not pay dividends.
How much money does Direxion Daily S&P Biotech Bear 3X Shares make?

Direxion Daily S&P Biotech Bear 3X Shares has a market capitalization of 67.84M.
What is Direxion Daily S&P Biotech Bear 3X Shares's stock symbol?

Direxion Daily S&P Biotech Bear 3X Shares is traded on the AMEX under the ticker symbol "LABD".
What is Direxion Daily S&P Biotech Bear 3X Shares's primary industry?

Company operates in the Financial Services sector and Asset Management - Leveraged industry.
How do i buy shares of Direxion Daily S&P Biotech Bear 3X Shares?

Shares of Direxion Daily S&P Biotech Bear 3X Shares can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When Direxion Daily S&P Biotech Bear 3X Shares went public?

Direxion Daily S&P Biotech Bear 3X Shares is publicly traded company for more then 10 years since IPO on 28 May 2015.

Direxion Daily S&P Biotech Bear 3X Shares

Exchange:

AMEX

Full time employees:

Industry:

Asset Management - Leveraged

Sector:

Financial Services

The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

CIK: 0001424958
ISIN: US25460G7161
: